6920:TSELasertec Corp. Analysis
Data as of 2026-07-31 - not real-time
NT$70.90
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Phoenix Pioneer technology Co., Ltd. (6920.TWO) is trading at TWD 70.9, marginally above its DCF‑derived fair value of TWD 69.4, suggesting a slight premium. The stock sits below its 20‑day (≈TWD 82) and 50‑day (≈TWD 98) simple moving averages, while the 200‑day SMA (≈TWD 60) lies just under the current price, indicating a neutral to mildly bearish technical backdrop. Momentum indicators reinforce this view: the RSI is at 37, hinting at oversold conditions, yet the MACD histogram is negative and the MACD signal is labeled “bearish.”
Fundamentally, the company posts robust revenue growth of 22.6% but suffers from deep negative margins (gross ‑15.5%, operating ‑23.2%, net ‑31.9%) and a high debt‑to‑equity ratio of roughly 75%, with a beta well above 1, a 30‑day volatility of over 80%, and a max drawdown exceeding 54%, all of which amplify risk despite a solid cash position.
Fundamentally, the company posts robust revenue growth of 22.6% but suffers from deep negative margins (gross ‑15.5%, operating ‑23.2%, net ‑31.9%) and a high debt‑to‑equity ratio of roughly 75%, with a beta well above 1, a 30‑day volatility of over 80%, and a max drawdown exceeding 54%, all of which amplify risk despite a solid cash position.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price slightly above DCF fair value
- Bearish MACD and price below short‑term SMAs
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained revenue growth but persistent negative profitability
- Elevated debt levels and high beta increasing market sensitivity
- Absence of dividend and weak cash conversion
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if margins improve and debt is deleveraged
- Valuation near fair value limits upside potential
- Sector cyclicality and geopolitical exposure in Taiwan
Key Metrics & Analysis
Financial Health
Revenue Growth22.60%
Profit Margin-31.90%
ROE-31.20%
ROA-7.72%
Debt/Equity74.65
P/B Ratio9.3
Op. Cash FlowNT$60.0M
Free Cash FlowNT$465.2M
Industry P/E32.9
Technical Analysis
TrendNeutral
RSI37.4
SupportNT$57.00
ResistanceNT$106.00
MA 20NT$82.07
MA 50NT$98.11
MA 200NT$59.90
MACDBearish
VolumeStable
Fear & Greed Index90.91
Valuation
Fair ValueNT$69.39
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.25
Volatility81.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.